Events
The U.S. – and global – response to the COVID-19 pandemic has been volatile at best. This is fair, considering that SARS-CoV-2 is a novel virus with a lethality we haven’t seen in more than a century.
October is Breast Cancer Awareness month, and Daiichi Sankyo is aiming to raise awareness about one of the most common forms of cancer across the globe.
Pfizer is continuing to invest in gene therapy research and development and other areas going on throughout the company, specifically in its North Carolina sites in Chapel Hill and Kit Creek.
The use of structured data and automation can accelerate antibody engineering as much as 50%, Prem Mohanty, product marketing manager and life sciences product specialist for Benchling, told BioSpace.
Free Lonza webinar to discuss the benefits of using physiologically relevant 3D cell culture models to enhance respiratory research for diseases like COVID-19
A summary of daily biopharma industry news. Please check out stories that are trending on March 27, 2020.
A summary of daily biopharma industry news. Please check out stories that are trending on March 24, 2020.
A summary of daily biopharma industry news. Please check out stories that are trending on March 23, 2020.
MassBio® announced the two keynote speakers for its annual State of Possible Conference taking place March 25-26, 2020 at the Royal Sonesta in Cambridge: Billy Starr, Founder and Executive Director, Pan-Mass Challenge; and Susan Hockfield, Ph.D., President Emerita, MIT.
Recipharm has announced its 2019 International Environmental Award will be presented to Dana Kolpin, Research Hydrologist at the U.S. Geological Survey Central Midwest Water Science Center in Iowa City, Iowa.
PRESS RELEASES